Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

Go back to Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
NORTHWEST BIO (AMEX: NWBO) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High $5.19 
Open $0.20    52 Week Low $0.32 
Day High $0.20    P/E N/A 
Day Low $0.19    EPS $-3.72 
Volume 2,283,691